These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 31696985)
1. Conventional plasmid DNAs with a CpG-containing backbone achieve durable transgene expression in mouse liver. Suzuki T; Wakao Y; Goda T; Kamiya H J Gene Med; 2020 Jan; 22(1):e3138. PubMed ID: 31696985 [TBL] [Abstract][Full Text] [Related]
2. Durable Transgene Expression Driven by CpG-Free and -Containing Promoters in Plasmid DNA with CpG-Free Backbone. Suzuki T; Goda T; Kamiya H Biol Pharm Bull; 2018; 41(9):1489-1493. PubMed ID: 30175785 [TBL] [Abstract][Full Text] [Related]
3. Sustained, high transgene expression in liver with plasmid vectors using optimized promoter-enhancer combinations. Magnusson T; Haase R; Schleef M; Wagner E; Ogris M J Gene Med; 2011 Jul; 13(7-8):382-91. PubMed ID: 21721074 [TBL] [Abstract][Full Text] [Related]
4. High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter. Yew NS; Przybylska M; Ziegler RJ; Liu D; Cheng SH Mol Ther; 2001 Jul; 4(1):75-82. PubMed ID: 11472109 [TBL] [Abstract][Full Text] [Related]
15. Persistence of plasmid-mediated expression of transgenes in human mesenchymal stem cells depends primarily on CpG levels of both vector and transgene. Bruter AV; Kandarakov OF; Belyavsky AV J Gene Med; 2018 Feb; 20(2-3):e3009. PubMed ID: 29424052 [TBL] [Abstract][Full Text] [Related]
16. Correlation between transgen expression and plasmid DNA loss in mouse liver. Togashi R; Harashima H; Kamiya H J Gene Med; 2013; 15(6-7):242-8. PubMed ID: 23765503 [TBL] [Abstract][Full Text] [Related]
17. Low generation PAMAM dendrimer and CpG free plasmids allow targeted and extended transgene expression in tumors after systemic delivery. Navarro G; Maiwald G; Haase R; Rogach AL; Wagner E; de Ilarduya CT; Ogris M J Control Release; 2010 Aug; 146(1):99-105. PubMed ID: 20438778 [TBL] [Abstract][Full Text] [Related]
18. Myocardial injection of CA promoter-based plasmid mediates efficient transgene expression in rat heart. Huang J; Ito Y; Kobune M; Sasaki K; Nakamura K; Dehari H; Takahashi K; Ikeda K; Uchida H; Kato K; Hamada H J Gene Med; 2003 Oct; 5(10):900-908. PubMed ID: 14533199 [TBL] [Abstract][Full Text] [Related]
19. CpG methylation of a plasmid vector results in extended transgene product expression by circumventing induction of immune responses. Reyes-Sandoval A; Ertl HC Mol Ther; 2004 Feb; 9(2):249-61. PubMed ID: 14759809 [TBL] [Abstract][Full Text] [Related]
20. Efficient in vivo transfection and safety profile of a CpG-free and codon optimized luciferase plasmid using a cationic lipophosphoramidate in a multiple intravenous administration procedure. Lindberg MF; Le Gall T; Carmoy N; Berchel M; Hyde SC; Gill DR; Jaffrès PA; Lehn P; Montier T Biomaterials; 2015 Aug; 59():1-11. PubMed ID: 25941996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]